Quality Assurance and Safety of Herbal Dietary Supplements

REFERENCES

• Zurer , P and Hanson , D . 2004 . Chemistry puts herbal supplements to the test . Chemical & Engineering News , 82 ( 14 ) : 16
   Web of Science ®Google Scholar
• Lee , F SC , Wang , X and Fu , P P . Good Agriculture Practice (GAP) for the quality assurance and safety protection of traditional Chinese herbs used in dietary supplements . Am Chem Soc Monograph , in press
   Google Scholar
• 2003 . FDA Proposal for Dietary Supplements Current. Good Manufacturing Practices (CGMPs) Available at: http://www.cfsan.fda.gov/~dms/dscgmps3.html
   Google Scholar
• World Health Organization . 2003 . Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants , Nonserial Publication .
   Google Scholar
• Hu , S L . 1997 . A study of Chinese genuine herbs , Bejing, , China : Chinese Medicine Publishing Inc .
   Google Scholar
• Chan , S S , Li , S L and Lin , G . 2007 . Pitfalls of the selection of chemical markers for the quality control of medicinal herbs . J Food Drug Anal , 15 : 365 – 371 .
   Web of Science ®Google Scholar
• Chan , P C , Xia , Q and Fu , P P . 2007 . Ginkgo biloba leave extract: biological, medicinal, and toxicological effects . Environ Carcinogen Ecotoxicol Rev , 25 : 211 – 244 .
   PubMed Web of Science ®Google Scholar
• Liu , Y , Liu , S H , Wang , J Q and Sun , S Q . 2007 . Progress in application of infrared spectroscopy and comparative study of chromatographic fingerprints . Guangpuxue Yu Guangpu Fenxi , 27 : 1093 – 1097 .
   PubMedGoogle Scholar
• Chen , J , Lee , F SC , Li , L , Yang , B and Wang , X . 2007 . Standardized Extracts of Chinese Medicinal Herbs: Case Study of Danshen (Salvia miltiorrhiza Bunge). J . Food Drug Anal , 15 : 347 – 364 .
   Web of Science ®Google Scholar
• Chan , S S , Cheng , T Y and Lin , G . 2007 . Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta . J Ethnopharmacol , 111 : 677 – 680 .
   PubMed Web of Science ®Google Scholar
• Li , S L , Lin , G and Tam , Y K . 2006 . Time-course accumulation of main bioactive components in the rhizome of Ligusticum chuanxiong . Planta Med , 72 : 278 – 280 .
   PubMed Web of Science ®Google Scholar
• Li , S L , Yan , R , Tam , Y K and Lin , G . 2007 . Post-harvest alteration of the main chemical ingredients in Ligusticum chuanxiong . Hort Chem Pharm Bul , 55 : 140 – 144 .
   PubMed Web of Science ®Google Scholar
• Wu , J and Li , L . 2004 . Determination of the residues of eleven organophosphorus insecticides in Job's-tears by gas chromatography with a nitrogen-phosphorus detector . J AOAC Int , 87 ( 5 ) : 1260 – 1263 .
   PubMed Web of Science ®Google Scholar
• Leung , K S , Chan , K , Chan , C L and Lu , G H . 2005 . Systematic evaluation of organochlorine pesticide residues in Chinese materia medica . Phytother Res , 19 ( 6 ) : 514 – 8 .
   PubMed Web of Science ®Google Scholar
• Hao , L L and Xue , J . 2005 . Multiresidue analysis of organochlorine pesticides and the application to Chinese herbal medicine . Zhongguo Zhong Yao Za Zhi , 30 ( 6 ) : 405 – 9 .
   PubMedGoogle Scholar
• Tam , J W , Dennehy , C E , Ko , R and Tsourounis , C . 2006 . Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003 . J Herb Pharmacother , 6 ( 2 ) : 1 – 19 .
   PubMedGoogle Scholar
• Lai , L , Liu , F-S , Hsu , Y-H , Yu , C-L , Hsiao , S-H , Lo , C-F and Lin , J-H . 2006 . Survey of heavy metals in raw material of traditional Chinese medinice (I), Annual Scientific Report of Bureau of Food and Drug Analysis, Department of Health . Executive Yuan , 24 : 228 – 241 .
   Google Scholar
• Lai , L , Tseng , J-H , Chen , Y-H , Lo , C-F and Lin , J-H . 2006 . Survey of heavy metals in raw material of traditional Chinese medinice (II), Annual Scientific Report of Bureau of Food and Drug Analysis, Department of Health . Executive Yuan , 24 : 242 – 256 .
   Google Scholar
• Lai , L , Liu , F-S , Hsu , Y-H , Yu , C-L , Hsiao , S-H , Lo , C-F and Lin , J-H . 2006 . Survey of organochlorine pesticide residues in raw material of traditional Chinese medinice (I), Annual Scientific Report of Bureau of Food and Drug Analysis, Department of Health . Executive Yuan , 24 : 257 – 264 .
   Google Scholar
• Lai , L , Chin , L , Chen , Y-H , Lo , C-F and Lin , J-H . 2006 . Survey of organochlorine pesticide residues in Chinese herbs and pharmaceutical products (II), Annual Scientific Report of Bureau of Food and Drug Analysis, Department of Health . Executive Yuan , 24 : 265 – 273 .
   Google Scholar
• Wong , T C , Chang , L , Lee , F SC , Wang , X and Fu , P P . 2007 . A Survey of Heavy Metals and Organochlorine Pesticides Contaminations in Commercial Ling Zhi Products . J Food Drug Anal , 15 : 472 – 479 .
   Web of Science ®Google Scholar
• Mustafa , O , Brendan , M and Pei , C . 2007 . Comparison of the terpene lactones and flavonols contents in G. Biloba commercial samples and the NIST standard reference materials using LC/UV/MS . J Food Drug Anal , 15 : 55 – 62 .
   Web of Science ®Google Scholar
• FDA . 2005 . Warning on Imported Ginseng . FDA Consumer , 39 ( 2 )
   Google Scholar
• Pailer , M I , Belohlav , I and Simonitsch , E . 1955 . Konstitution der Aristolochiasauren . Monatsh Chem , 86 : 676 – 680 .
   Google Scholar
• Schwetz , B A . 2001 . From the Food and Drug Administration . JAMA , 285 : 2705
   PubMedGoogle Scholar
• FDA . 2001 . Dietary Supplements: Aristolochic Acid Available at: http://www.cfsan.fda.gov/~dms/ds-bot.html
   Google Scholar
• Gold , L S and Slone , T H . 2003 . Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert . N Engl J Med , 349 : 1576 – 1577 .
   PubMed Web of Science ®Google Scholar
• Martena , M J , van der Wielen , J C , van de Laak , L F , Konings , E J , de Groot , H N and Rietjens , I M . 2007 . Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market . Anal Bioanal Chem , 389 : 263 – 275 .
   PubMed Web of Science ®Google Scholar
• Cheung , T P , Xue , C , Leung , K , Chan , K and Li , C G . 2006 . Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products—a consequence of inappropriate nomenclature and imprecise labelling? . Clin Toxicol (Phila) , 44 : 371 – 378 .
   PubMed Web of Science ®Google Scholar
• Yang , H Y , Lin , J L , Chen , K H , Yu , C C , Hsu , P Y and Lin , C L . 2006 . Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin . J Nephrol , 19 : 111 – 114 .
   PubMed Web of Science ®Google Scholar
• IARC . 2002 . “ Some traditional herbal medicines, some mycotoxins, naphtalene and styrene ” . In IARC monographs on the evaluation of carcinogenic risks of chemical to humans , Lyon, , France : IARC .
   Google Scholar
• Nortier , J L , Martinez , M C , Schmeiser , H H , Arlt , V M , Bieler , C A , Petein , M , Depierreux , M F , De Pauw , L , Abramowicz , D and Vereerstraeten , P . 2000 . Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . N Engl J Med , 342 : 1686 – 1692 .
   PubMed Web of Science ®Google Scholar
• Vanherweghem , J L , Tielemans , C , Simon , J and Depierreux , M . 1995 . Chinese herbs nephropathy and renal pelvic carcinoma . Nephrol Dial Transplant , 10 : 270 – 273 .
   PubMed Web of Science ®Google Scholar
• Mengs , U . 1987 . Acute toxicity of aristolochic acid in rodents . Arch Toxicol , 59 : 328 – 331 .
   PubMed Web of Science ®Google Scholar
• Mengs , U and Stotzem , C D . 1993 . Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology . Arch Toxicol , 67 : 307 – 311 .
   PubMed Web of Science ®Google Scholar
• Arlt , V M , Schmeiser , H H and Pfeifer , G P . 2001 . Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR . Carcinogenesis , 22 : 133 – 140 .
   PubMed Web of Science ®Google Scholar
• Robisch , G , Schimmer , O and Goggelmann , W . 1982 . Aristolochic acid is a direct mutagen in Salmonella typhimurium . Mutat Res , 105 : 201 – 204 .
   PubMed Web of Science ®Google Scholar
• Zhang , H , Cifone , M A , Murli , H , Erexson , G L , Mecchi , M S and Lawlor , T E . 2004 . Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid . Food Chem Toxicol , 42 : 2021 – 2028 .
   PubMed Web of Science ®Google Scholar
• Mengs , U . 1983 . On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid . Arch Toxicol , 52 : 209 – 220 .
   PubMed Web of Science ®Google Scholar
• Mengs , U . 1988 . Tumour induction in mice following exposure to aristolochic acid . Arch Toxicol , 61 : 504 – 505 .
   PubMed Web of Science ®Google Scholar
• Lord , G M , Cook , T , Arlt , V M , Schmeiser , H H , Williams , G and Pusey , C D . 2001 . Urothelial malignant disease and Chinese herbal nephropathy . Lancet , 358 : 1515 – 1516 .
   PubMed Web of Science ®Google Scholar
• Vishwanath , B S and Gowda , T V . 1987 . Interaction of aristolochic acid with Vipera russelli phospholipase A2: its effect on enzymatic and pathological activities . Toxicon , 25 : 929 – 937 .
   PubMed Web of Science ®Google Scholar
• Vanherweghem , J L , Depierreux , M , Tielemans , C , Abramowicz , D , Dratwa , M , Jadoul , M , Richard , C , Vandervelde , D , Verbeelen , D and Vanhaelen-Fastre , R . 1993 . Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs . Lancet , 341 : 387 – 391 .
   PubMed Web of Science ®Google Scholar
• Cosyns , J P , Jadoul , M , Squifflet , J P , De Plaen , J F , Ferluga , D and van Ypersele de Strihou , C . 1994 . Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? . Kidney Int , 45 : 1680 – 1688 .
   PubMed Web of Science ®Google Scholar
• Depierreux , M , Van Damme , B , Vanden Houte , K and Vanherweghem , J L . 1994 . Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs . Am J Kidney Dis , 24 : 172 – 180 .
   PubMed Web of Science ®Google Scholar
• Vanherweghem , L J . 1998 . Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) . J Altern Complement Med , 4 : 9 – 13 .
   PubMed Web of Science ®Google Scholar
• Vanhaelen , M , Vanhaelen-Fastre , R , But , P and Vanherweghem , J L . 1994 . Identification of aristolochic acid in Chinese herbs . Lancet , 343 : 174
   PubMed Web of Science ®Google Scholar
• Nortier , J L , Schmeiser , H H , Muniz Martinez , M C , Arlt , V M , Vervaet , C , Garbar , C H , Daelemans , P and Vanherweghem , J L . 2003 . Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure . Nephrol Dial Transplant , 18 : 426 – 428 .
   PubMed Web of Science ®Google Scholar
• Cronin , A J , Maidment , G , Cook , T , Kite , G C , Simmonds , M S , Pusey , C D and Lord , G M . 2002 . Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy . Nephrol Dial Transplant , 17 : 524 – 525 .
   PubMed Web of Science ®Google Scholar
• Schmeiser , H H , Bieler , C A , Wiessler , M , van Ypersele de Strihou , C and Cosyns , J P . 1996 . Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy . Cancer Res , 56 : 2025 – 2028 .
   PubMed Web of Science ®Google Scholar
• Lord , G M , Hollstein , M , Arlt , V M , Roufosse , C , Pusey , C D , Cook , T and Schmeiser , H H . 2004 . DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy . Am J Kidney Dis , 43 : e11 – 17 .
   PubMed Web of Science ®Google Scholar
• Arlt , V M , Alunni-Perret , V , Quatrehomme , G , Ohayon , P , Albano , L , Gaid , H , Michiels , J F , Meyrier , A , Cassuto , E and Wiessler , M . 2004 . Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer . Int J Cancer , 111 : 977 – 980 .
   PubMed Web of Science ®Google Scholar
• Cui , M , Liu , Z H , Qiu , Q , Li , H and Li , L S . 2005 . Tumour induction in rats following exposure to short-term high dose aristolochic acid I . Mutagenesis , 20 : 45 – 49 .
   PubMed Web of Science ®Google Scholar
• Cosyns , J P , Dehoux , J P , Guiot , Y , Goebbels , R M , Robert , A , Bernard , A M and van Ypersele de Strihou , C . 2001 . Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? . Kidney Int , 59 : 2164 – 2173 .
   PubMed Web of Science ®Google Scholar
• Gold , L and Zeiger , E , eds. 1997 . Handbook of carcinogenic potency and genotoxicity databases , Boca Raton, Fla : CRC Press . Available at: http://potency.berkeley.edu/
   Google Scholar
• Chen , L , Mei , N , Yao , L and Chen , T . 2006 . Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats . Toxicol Lett , 165 : 250 – 256 .
   PubMed Web of Science ®Google Scholar
• Chen , T , Guo , L , Zhang , L , Shi , L , Fang , H , Sun , Y , Fuscoe , J C and Mei , N . 2006 . Gene Expression Profiles Distinguish the Carcinogenic Effects of Aristolochic Acid in Target (Kidney) and Non-target (Liver) Tissues in Rats . BMC Bioinformatics , 2 ( 7 Suppl ) : S20
   Google Scholar
• Chen , T . 2007 . Genotoxicity of Aristolochic acid: A Review . J Food Drug Anal , 15 : 387 – 399 .
   Web of Science ®Google Scholar
• Kessler , D A . 2000 . Cancer and herbs . N Engl J Med , 342 : 1742 – 1743 .
   PubMed Web of Science ®Google Scholar
• Schwetz , B A . 2001 . From the Food and Drug Administration . JAMA , 285 : 2705 Available at: http://www.cfsan.fda.gov/~dms/ds-bot.html
   PubMedGoogle Scholar
• National Toxicology Program (NTP) . 2008 . Report on Carcinogens Background Document for Aristolochic Acid , Research Triangle Park, NC : NTP .
   Google Scholar
• IARC (International Agency for Research in Cancer) . 1976 . “ Pyrrolizidine alkaloids ” . In IARC Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man—Some Naturally Occurring Substance , vol. 10 , 265 – 342 . Lyon, , France : International Agency for Research on Cancer .
   Google Scholar
• Mattocks , A R . 1986 . Chemistry and toxicology of pyrrolizidine alkaloids , London : Academic Press .
   Google Scholar
• Fu , P P , Xia , Q , Lin , G and Chou , M W . 2004 . Genotoxic pyrrolizidine alkaloids—mechanisms leading to DNA adduct formation and tumorigenicity . Drug Metab Rev , 36 : 1 – 55 .
   PubMed Web of Science ®Google Scholar
• Chan , P C , Haseman , J K , Prejean , J D and Nyska , A . 2003 . Toxicity and carcinogenicity of riddelliine in rats and mice . Toxicol Lett , 144 : 295 – 311 .
   PubMed Web of Science ®Google Scholar
• Molyneux , J O , Cooke , M P , King , R R and Mohamed , P A . 1990 . Pyrrolizidine alkaloids in milk; thresholds of toxication . Vet Hum Toxicol , 32 : 94 – 103 .
   PubMedGoogle Scholar
• Betz , J M , Eppley , R M , Taylor , W C and Andrzejewski , D . 1994 . Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.) . J Pharm Sci , 83 : 649 – 653 .
   PubMed Web of Science ®Google Scholar
• Prakash , A S , Pereira , T N , Reilly , P E and Seawright , A A . 1999 . Pyrrolizidine alkaloids in human diet . Mutat Res , 443 : 53 – 67 .
   PubMed Web of Science ®Google Scholar
• Chou , M W and Fu , P P . 2006 . Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids . Toxicol Ind Health , 22 : 321 – 327 .
   PubMed Web of Science ®Google Scholar
• International Programme on Chemical Safety (IPCS) . 1989 . Pyrrolizidine Alkaloids Health and Safety Guide. Health and Safety Criteria Guide 26 , Geneva : WHO .
   Google Scholar
• Yang , Y C , Yan , J , Doerge , D R , Chan , P-C , Fu , P P and Chou , M W . 2001 . Metabolic activation of the tumorigenic pyrrolizidine alkaloids, riddelliine, leading to DNA adduct formation in vivo . Chem Res Toxicol , 14 : 101 – 109 .
   PubMed Web of Science ®Google Scholar
• Chou , M W , Jian , Y , Williams , L D , Xia , Q , Churchwell , M , Doerge , D R and Fu , P P . 2003 . Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid . Chem Res Toxicol , 16 : 1130 – 1137 .
   PubMed Web of Science ®Google Scholar
• Chou , M W , Yan , J , Nichols , J , Xia , Q , Beland , F A , Chan , P C and Fu , P P . 2003 . Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F(1) mice . Cancer Lett , 193 : 119 – 125 .
   PubMed Web of Science ®Google Scholar
• Xia , Q , Chou , M W , Kadlubar , F F , Chan , P-C and Fu , P P . 2003 . Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine . Chem Res Toxicol , 16 : 66 – 73 .
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP) . 2008 . Report on Carcinogens . Federal Register , 73 ( 84 )
   Google Scholar
• Fu , P P , Xia , Q , Chou , M W and Lin , G . 2007 . Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements . J Food Drug Anal , 15 : 400 – 415 .
   Web of Science ®Google Scholar
• Roeder , E . 2000 . Medicinal plants in China containing pyrrolizidine alkaloids . Pharmazie , 55 : 711 – 726 .
   PubMed Web of Science ®Google Scholar
• McLean , E K . 1970 . The toxic actions of pyrrolizidine (senecio) alkaloids . Pharmacol Rev , 22 : 429 – 483 .
   PubMedGoogle Scholar
• Lin , G , Cui , Y Y and Hawes , E M . 2000 . Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid . Drug Metab Dispos , 28 : 1475 – 1483 .
   PubMed Web of Science ®Google Scholar
• Fu , P P , Yang , Y-C , Xia , X , Chou , M W , Cui , Y Y and Lin , G . 2002 . Pyrrolizidine alkaloids—tumorigenic components in Chinese herbal medicines and dietary supplements . J Food Drug Analy , 10 : 198 – 211 .
   Web of Science ®Google Scholar
• Li , S-L , Lin , G , Fu , P P , Chan , C-L , Li , M , Jiang , Z-H and Zhao , Z-H . 2008 . Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis Scandentis (Qianliguang) . Rapid Commun Mass Spect , 22 : 591 – 602 .
   PubMed Web of Science ®Google Scholar
• Yan , J , Xia , Q , Fu , P P and Chou , M W . 2008 . Metabolic activation of retronecine and retronecine N-oxide—formation of DHP-derived DNA adducts . Toxicol Ind Health , 24 : 181 – 188 .
   PubMed Web of Science ®Google Scholar
• Wang , Y-P , Yan , J , Beger , R D , Fu , P P and Chou , M W . 2005 . Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo . Cancer Lett , 226 : 27 – 35 .
   PubMed Web of Science ®Google Scholar
• Xia , Q , Chou , M W , Lin , G and Fu , P P . 2004 . Formation of DHP-derived DNA adducts from metabolic activation of clivorine, a presentative otonecine-type pyrrolizidine alkaloid, and Ligularia hodgsonnii hook plant extract . Chem Res Toxicol , 17 : 702 – 708 .
   PubMed Web of Science ®Google Scholar
• Xia , Q , Chou , M W , Edgar , J A , Doerge , D R and Fu , P P . 2006 . Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine . Cancer Lett , 231 : 138 – 145 .
   PubMed Web of Science ®Google Scholar
• Xia , Q , Yan , J , Chou , M W and Fu , P P . 2008 . Formation of DHP-derived DNA adducts from metabolic activation of heliotrine . Toxicol Lett , 178 : 77 – 82 .
   PubMed Web of Science ®Google Scholar
• Mossoba , M M , Lin , S H , Andrzejewski , D and Sphon , J A . 1994 . Application of gas chromatography/matrix isolation/fourier transform infrared spectroscopy to the identification of pyrrolizidine alkaloids from comfrey root (Symphytum officinale L.) . J AOAC Int , 77 ( 5 ) : 1167 – 1174 .
   Web of Science ®Google Scholar
• Snider , S . 1991 . Beware the unknown brew. Herbal Teas and Toxicity . FDA Consumer , 25 ( 4 ) : 30 – 33 .
   Google Scholar
• Vollmer , J J , Steiner , N C , Larsen , G Y , Muirhead , K M and Molyneux , R J . 1987 . Pyrrolizidine alkaloids: testing for toxic constituents of comfrey . J Chem Educ , 64 ( 12 ) : 1027 – 1030 .
   Web of Science ®Google Scholar
• D'Arcy , P F . 1991 . Adverse reactions and interactions with herbal medicines. Part 1. Adverse reactions . Adverse Drug React Toxicol Rev , 10 ( 4 ) : 189 – 208 .
   PubMedGoogle Scholar
• Bent , S , Goldberg , H , Padula , A and Avins , A L . 2005 . Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature . J Gen Intern Med , 20 ( 7 ) : 657 – 61 .
   PubMed Web of Science ®Google Scholar
• Rowin , J and Lewis , S L . 1996 . Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion . Neurology , 46 ( 6 ) : 1775 – 6 .
   PubMed Web of Science ®Google Scholar
• Al-Yahya , A A , Al-Majed , A A , Al-Bekairi , A M , Al-Shabanah , O A and Qureshi , S . 2006 . Studies on the reproductive, cytological and biochemical toxicity of Ginkgo Biloba in Swiss albino mice . J Ethnopharmacol , 107 ( 2 ) : 222 – 8 .
   PubMed Web of Science ®Google Scholar
• Yamashita , N and Kawanishi , S . 2000 . Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin . Free Radic Res , 33 ( 5 ) : 623 – 33 .
   PubMed Web of Science ®Google Scholar
• Boots , A W , Balk , J M , Bast , A and Haenen , G R . 2005 . The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity . Biochem Biophys Res Commun , 338 ( 2 ) : 923 – 929 .
   PubMed Web of Science ®Google Scholar
• Boersma , M G , Vervoort , J , Szymusiak , H , Lemanska , K , Tyrakowska , B , Cenas , N , Segura-Aguilar , J and Rietjens , I M . 2000 . Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide . Chem Res Toxicol , 13 ( 3 ) : 185 – 91 .
   PubMed Web of Science ®Google Scholar
• Choi , E J , Lee , B H , Lee , K and Chee , K M . 2005 . Long-term combined administration of quercetin and daidzein inhibits quercetin-induced suppression of glutathione antioxidant defenses . Food Chem Toxicol , 43 ( 5 ) : 793 – 8 .
   PubMed Web of Science ®Google Scholar
• Walle , T , Vincent , T S and Walle , U K . 2003 . Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells . Biochem Pharmacol , 65 ( 10 ) : 1603 – 10 .
   PubMed Web of Science ®Google Scholar
• van der Woude , H , Alink , G M , van Rossum , B E , Walle , K , van Steeg , H , Walle , T and Rietjens , I M . 2005 . Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity . Chem Res Toxicol , 18 ( 12 ) : 1907 – 16 .
   PubMed Web of Science ®Google Scholar
• Crebelli , R , Aquilina , G , Falcone , E and Carere , A . 1987 . Urinary and faecal mutagenicity in Sprague-Dawley rats dosed with the food mutagens quercetin and rutin . Food Chem Toxicol , 25 ( 1 ) : 9 – 15 .
   PubMed Web of Science ®Google Scholar
• NTP . 1992 . Toxicology and Carcinogenesis Studies of Quercetin , Research Triangle Park, NC : National Toxicology Program . (CAS No. 117-39-5) in F344/N Rats (Feed Studies). Report nr Technical Report Series No. 409
   Google Scholar
• Clouatre , D L . 2004 . Kava kava: examining new reports of toxicity . Toxicol Lett , 150 : 85 – 96 .
   PubMed Web of Science ®Google Scholar
• Singh , Y N . 2005 . Potential for interaction of kava and St. John's wort with drugs . J Ethnopharmacol , 100 : 108 – 113 .
   PubMed Web of Science ®Google Scholar
• Fu , P P , Xia , Q , Guo , L , Yu , H and Chan , P-C . 2008 . Toxicity of kava kava . J Environ Sci Health, Part C, Environ Carcinogen Ecotocicol Rev , 26 : 89 – 112 .
   PubMed Web of Science ®Google Scholar
• Humberston , C L , Akhtar , J and Krenzelok , E P . 2003 . Acute hepatitis induced by kava kava . J Toxicol Clin Toxicol , 41 : 109 – 113 .
   PubMed Web of Science ®Google Scholar
• Stickel , F , Baumuller , H M , Seitz , K , Vasilakis , D , Seitz , G , Seitz , H K and Schuppan , D . 2003 . Hepatitis induced by Kava (Piper methysticum rhizoma) . J Hepatol , 39 : 62 – 67 .
   PubMed Web of Science ®Google Scholar
• Center for Food Safety and Applied Nutrition (CFSAN) . March 25 2002 . U.S. Food and Drug Administration. A Consumer Advisory. Kava-containing dietary supplements may be associated with severe liver injury , March 25 , Rockville, , Maryland : U.S. Department of Health and Human Services, Food and Drug Administration . Available at: http://www.cfsan.fda.gov/~dms/ds-warn.html
   Google Scholar
• Whitton , P A , Lau , A , Salisbury , A , Whitehouse , J and Evans , C S . 2003 . Kava lactones and the kava-kava controversy . Phytochemistry , 64 : 673 – 679 .
   PubMed Web of Science ®Google Scholar
• Eichelbaum , M , Kroemer , H K and Fromm , M F . 1997 . Impact of P450 genetic polymorphism on the first-pass extraction of cardiovascular and neuroactive drugs . Adv Drug Deliv Rev , 27 : 171 – 199 .
   PubMed Web of Science ®Google Scholar
• Mathews , J D , Riley , M D , Fejo , L , Munoz , E , Milns , N R , Gardner , I D , Powers , J R , Ganygulpa , E and Gununuwawuy , B J . 1988 . Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community . Med J Aust , 148 : 548 – 555 .
   PubMed Web of Science ®Google Scholar
• Zou , L , Harkey , M R and Henderson , G L . 2002 . Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity . Life Sci , 71 ( 13 ) : 1579 – 89 .
   PubMed Web of Science ®Google Scholar
• Mathews , J M , Etheridge , A S and Black , S R . 2002 . Inhibition of human cytochrome P450 activities by kava extract and kavalactones . Drug Metab Dispos , 30 : 1153 – 1157 .
   PubMed Web of Science ®Google Scholar
• Mathews , J M , Etheridge , A S , Valentine , J L , Black , S R , Coleman , D P , Patel , P , So , J and Burka , L T . 2005 . Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro . Drug Metab Dispos , 33 : 1555 – 1563 .
   PubMed Web of Science ®Google Scholar
• Bressler , R . 2005 . Herb-drug interactions: interactions between kava and prescription medications . Geriatrics , 60 : 24 – 25 .
   PubMed Web of Science ®Google Scholar
• Hu , Z , Yang , X , Ho , P C , Chan , S Y , Heng , P W , Chan , E , Duan , W , Koh , H L and Zhou , S . 2005 . Herb-drug interactions: a literature review . Drugs , 65 : 1239 – 1282 .
   PubMed Web of Science ®Google Scholar
• Clayton , N P , Yoshizawa , K , Kissling , G E , Burka , L T , Chan , P C and Nyska , A . 2007 . Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract . Exp Toxicol Pathol , 58 : 223 – 236 .
   PubMed Web of Science ®Google Scholar
• Kaplowitz , N . 2001 . Causality assessment versus guilt-by-association in drug hepatotoxicity . Hepatology , 33 : 308 – 310 .
   PubMed Web of Science ®Google Scholar
• Johnson , B M , Qiu , S X , Zhang , S , Zhang , F , Burdette , J E , Yu , L , Bolton , J L and van Breemen , R B . 2003 . Identification of novel electrophilic metabolites of piper methysticum Forst (Kava) . Chem Res Toxicol , 6 : 733 – 740 .
   Google Scholar
• Available at: http://www.cfsan.fda.gov/~dms/dscgmps7.html Federal Register. Final Rule and Interim final rule. June 25, 2007
   Google Scholar